vs
Side-by-side financial comparison of INDEPENDENT BANK CORP (IBCP) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Viridian Therapeutics, Inc.\DE is the larger business by last-quarter revenue ($70.6M vs $58.9M, roughly 1.2× INDEPENDENT BANK CORP). INDEPENDENT BANK CORP runs the higher net margin — 28.6% vs -49.0%, a 77.7% gap on every dollar of revenue.
Independent Bank is a bank headquartered in Grand Rapids, Michigan. The bank has 62 branches, all of which are in Michigan.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
IBCP vs VRDN — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.9M | $70.6M |
| Net Profit | $16.9M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | — | -56.7% |
| Net Margin | 28.6% | -49.0% |
| Revenue YoY | — | 81958.1% |
| Net Profit YoY | 8.2% | 54.9% |
| EPS (diluted) | $0.81 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $58.9M | — | ||
| Q4 25 | $58.3M | — | ||
| Q3 25 | $57.3M | $70.6M | ||
| Q2 25 | $55.9M | — | ||
| Q1 25 | $54.1M | — | ||
| Q4 24 | $62.0M | — | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $56.5M | — |
| Q1 26 | $16.9M | — | ||
| Q4 25 | $18.6M | — | ||
| Q3 25 | $17.5M | $-34.6M | ||
| Q2 25 | $16.9M | — | ||
| Q1 25 | $15.6M | — | ||
| Q4 24 | $18.5M | — | ||
| Q3 24 | $13.8M | — | ||
| Q2 24 | $18.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 34.8% | — | ||
| Q3 25 | 37.0% | -56.7% | ||
| Q2 25 | 37.0% | — | ||
| Q1 25 | 35.3% | — | ||
| Q4 24 | 36.7% | — | ||
| Q3 24 | 33.7% | — | ||
| Q2 24 | 41.0% | — |
| Q1 26 | 28.6% | — | ||
| Q4 25 | 31.8% | — | ||
| Q3 25 | 30.5% | -49.0% | ||
| Q2 25 | 30.2% | — | ||
| Q1 25 | 28.8% | — | ||
| Q4 24 | 29.8% | — | ||
| Q3 24 | 26.9% | — | ||
| Q2 24 | 32.8% | — |
| Q1 26 | $0.81 | — | ||
| Q4 25 | $0.88 | — | ||
| Q3 25 | $0.84 | — | ||
| Q2 25 | $0.81 | — | ||
| Q1 25 | $0.74 | — | ||
| Q4 24 | $0.87 | — | ||
| Q3 24 | $0.65 | — | ||
| Q2 24 | $0.88 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $174.9M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $510.6M | $503.0M |
| Total Assets | $5.6B | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $174.9M | — | ||
| Q4 25 | $138.4M | — | ||
| Q3 25 | $208.7M | $490.9M | ||
| Q2 25 | $146.2M | — | ||
| Q1 25 | $128.1M | — | ||
| Q4 24 | $119.9M | — | ||
| Q3 24 | $121.6M | — | ||
| Q2 24 | $214.3M | — |
| Q1 26 | $510.6M | — | ||
| Q4 25 | $503.0M | — | ||
| Q3 25 | $490.7M | $503.0M | ||
| Q2 25 | $469.3M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $454.7M | — | ||
| Q3 24 | $452.4M | — | ||
| Q2 24 | $430.5M | — |
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.5B | — | ||
| Q3 25 | $5.5B | $577.1M | ||
| Q2 25 | $5.4B | — | ||
| Q1 25 | $5.3B | — | ||
| Q4 24 | $5.3B | — | ||
| Q3 24 | $5.3B | — | ||
| Q2 24 | $5.3B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-84.6M |
| Free Cash FlowOCF − Capex | — | $-84.7M |
| FCF MarginFCF / Revenue | — | -120.1% |
| Capex IntensityCapex / Revenue | — | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $76.7M | — | ||
| Q3 25 | $18.2M | $-84.6M | ||
| Q2 25 | $19.0M | — | ||
| Q1 25 | $31.7M | — | ||
| Q4 24 | $63.2M | — | ||
| Q3 24 | $17.2M | — | ||
| Q2 24 | $8.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $70.2M | — | ||
| Q3 25 | $16.5M | $-84.7M | ||
| Q2 25 | $16.7M | — | ||
| Q1 25 | $30.6M | — | ||
| Q4 24 | $55.2M | — | ||
| Q3 24 | $15.7M | — | ||
| Q2 24 | $7.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 120.3% | — | ||
| Q3 25 | 28.9% | -120.1% | ||
| Q2 25 | 29.8% | — | ||
| Q1 25 | 56.5% | — | ||
| Q4 24 | 89.1% | — | ||
| Q3 24 | 30.6% | — | ||
| Q2 24 | 12.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.1% | — | ||
| Q3 25 | 2.9% | 0.2% | ||
| Q2 25 | 4.1% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 12.8% | — | ||
| Q3 24 | 2.9% | — | ||
| Q2 24 | 3.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 4.13× | — | ||
| Q3 25 | 1.04× | — | ||
| Q2 25 | 1.12× | — | ||
| Q1 25 | 2.03× | — | ||
| Q4 24 | 3.42× | — | ||
| Q3 24 | 1.25× | — | ||
| Q2 24 | 0.47× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IBCP
| Net Interest Income | $46.9M | 80% |
| Noninterest Income | $12.0M | 20% |
VRDN
Segment breakdown not available.
